FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953695354> ?p ?o ?g. }

• W2953695354 endingPage "15" @default.
• W2953695354 startingPage "3" @default.
• W2953695354 abstract "Introduction: Bivalirudin and heparin are the two most commonly used anticoagulants used during Percutaneous Coronary Intervention (PCI). The results of Randomized Controlled Trials (RCTs) comparing bivalirudin versus heparin monotherapy in the era of radial access are controversial, questioning the positive impact of bivalirudin on bleeding. The purpose of this systematic review is to summarize the results of RCTs comparing the efficacy and safety of bivalirudin versus heparin with or without Glycoprotein IIb/IIIa Inhibitors (GPI). Methods: This systematic review was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses PRISMA statements for reporting systematic reviews. We searched the National Library of Medicine PubMed, Clinicaltrial.gov and the Cochrane Central Register of Controlled Trials to include clinical studies comparing bivalirudin with heparin in patients undergoing PCI. Sixteen studies met inclusion criteria and were reviewed for the summary. Findings: Several RCTs and meta-analyses have demonstrated the superiority of bivalirudin over heparin plus routine GPI use in terms of preventing bleeding complications but at the expense of increased risk of ischemic complications such as stent thrombosis. The hypothesis of post- PCI bivalirudin infusion to mitigate the risk of acute stent thrombosis has been tested in various RCTs with conflicting results. In comparison, heparin offers the advantage of having a reversible agent, of lower cost and reduced incidence of ischemic complications. Conclusion: Bivalirudin demonstrates its superiority over heparin plus GPI with better clinical outcomes in terms of less bleeding complications, thus making it as anticoagulation of choice particularly in patients at high risk of bleeding. Further studies are warranted for head to head comparison of bivalirudin to heparin monotherapy to establish an optimal heparin dosing regimen and post-PCI bivalirudin infusion to affirm its beneficial effect in reducing acute stent thrombosis." @default.
• W2953695354 created "2019-07-12" @default.
• W2953695354 creator A5001577272 @default.
• W2953695354 creator A5002582638 @default.
• W2953695354 creator A5016962694 @default.
• W2953695354 creator A5019413011 @default.
• W2953695354 creator A5020863259 @default.
• W2953695354 creator A5041367100 @default.
• W2953695354 creator A5045742605 @default.
• W2953695354 creator A5087967324 @default.
• W2953695354 creator A5090648461 @default.
• W2953695354 date "2020-02-26" @default.
• W2953695354 modified "2023-09-27" @default.
• W2953695354 title "Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized Trials" @default.
• W2953695354 cites W1278248171 @default.
• W2953695354 cites W1421247184 @default.
• W2953695354 cites W1473004 @default.
• W2953695354 cites W1540336317 @default.
• W2953695354 cites W161671725 @default.
• W2953695354 cites W1766979050 @default.
• W2953695354 cites W1968369112 @default.
• W2953695354 cites W2012761317 @default.
• W2953695354 cites W2016463307 @default.
• W2953695354 cites W2019002307 @default.
• W2953695354 cites W2030271409 @default.
• W2953695354 cites W2073159589 @default.
• W2953695354 cites W2078904498 @default.
• W2953695354 cites W2082333685 @default.
• W2953695354 cites W2102296549 @default.
• W2953695354 cites W2102695511 @default.
• W2953695354 cites W2111460972 @default.
• W2953695354 cites W2112255365 @default.
• W2953695354 cites W2114758846 @default.
• W2953695354 cites W2121251309 @default.
• W2953695354 cites W2131387075 @default.
• W2953695354 cites W2134833483 @default.
• W2953695354 cites W2149011208 @default.
• W2953695354 cites W2156927593 @default.
• W2953695354 cites W2164624937 @default.
• W2953695354 cites W2170029016 @default.
• W2953695354 cites W2297611545 @default.
• W2953695354 cites W2335915210 @default.
• W2953695354 cites W2465763690 @default.
• W2953695354 cites W2512939430 @default.
• W2953695354 cites W2523777014 @default.
• W2953695354 cites W2550836649 @default.
• W2953695354 cites W2615685689 @default.
• W2953695354 cites W2622977531 @default.
• W2953695354 cites W2744105079 @default.
• W2953695354 cites W2745712984 @default.
• W2953695354 cites W4293372203 @default.
• W2953695354 cites W56633917 @default.
• W2953695354 cites W83328770 @default.
• W2953695354 cites W95276241 @default.
• W2953695354 doi "https://doi.org/10.2174/1871529x19666190626124057" @default.
• W2953695354 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7360918" @default.
• W2953695354 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31241442" @default.
• W2953695354 hasPublicationYear "2020" @default.
• W2953695354 type Work @default.
• W2953695354 sameAs 2953695354 @default.
• W2953695354 citedByCount "2" @default.
• W2953695354 countsByYear W29536953542021 @default.
• W2953695354 countsByYear W29536953542022 @default.
• W2953695354 crossrefType "journal-article" @default.
• W2953695354 hasAuthorship W2953695354A5001577272 @default.
• W2953695354 hasAuthorship W2953695354A5002582638 @default.
• W2953695354 hasAuthorship W2953695354A5016962694 @default.
• W2953695354 hasAuthorship W2953695354A5019413011 @default.
• W2953695354 hasAuthorship W2953695354A5020863259 @default.
• W2953695354 hasAuthorship W2953695354A5041367100 @default.
• W2953695354 hasAuthorship W2953695354A5045742605 @default.
• W2953695354 hasAuthorship W2953695354A5087967324 @default.
• W2953695354 hasAuthorship W2953695354A5090648461 @default.
• W2953695354 hasBestOaLocation W29536953541 @default.
• W2953695354 hasConcept C126322002 @default.
• W2953695354 hasConcept C164705383 @default.
• W2953695354 hasConcept C168563851 @default.
• W2953695354 hasConcept C17744445 @default.
• W2953695354 hasConcept C177713679 @default.
• W2953695354 hasConcept C189708586 @default.
• W2953695354 hasConcept C199539241 @default.
• W2953695354 hasConcept C2777557582 @default.
• W2953695354 hasConcept C2777565915 @default.
• W2953695354 hasConcept C2777698277 @default.
• W2953695354 hasConcept C2779473830 @default.
• W2953695354 hasConcept C2780400711 @default.
• W2953695354 hasConcept C45393284 @default.
• W2953695354 hasConcept C500558357 @default.
• W2953695354 hasConcept C71924100 @default.
• W2953695354 hasConceptScore W2953695354C126322002 @default.
• W2953695354 hasConceptScore W2953695354C164705383 @default.
• W2953695354 hasConceptScore W2953695354C168563851 @default.
• W2953695354 hasConceptScore W2953695354C17744445 @default.
• W2953695354 hasConceptScore W2953695354C177713679 @default.
• W2953695354 hasConceptScore W2953695354C189708586 @default.
• W2953695354 hasConceptScore W2953695354C199539241 @default.
• W2953695354 hasConceptScore W2953695354C2777557582 @default.
• W2953695354 hasConceptScore W2953695354C2777565915 @default.

• next